Huhtaniemi, Riikka
30  results:
Search for persons X
?
5

Discovery and development of ODM-204: A Novel nonsteroidal ..:

Oksala, Riikka ; Moilanen, Anu ; Riikonen, Reetta...
The Journal of Steroid Biochemistry and Molecular Biology.  192 (2019)  - p. 105115 , 2019
 
?
6

SUN-213 Hsd17b3 Knockout Mice Serve As A Model To Define Me..:

Poutanen, Matti ; Junnila, Arttu ; Zhang, Fu-Ping...
Journal of the Endocrine Society.  3 (2019)  Supplement_1 - p. , 2019
 
?
9

Structural mechanism for inhibition of PP2A-B56α and oncoge..:

Pavic, Karolina ; Gupta, Nikhil ; Domènech Omella, Judit...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41467-023-36693-9.  , 2023
 
?
12

PP2A-based triple-strike therapy overcomes mitochondrial ap..:

Denisova, Oxana V ; Merisaari, Joni ; Huhtaniemi, Riikka...
Denisova, Oxana V. Merisaari, Joni Huhtaniemi, Riikka Qiao, Xi Yetukuri, Laxman Jumppanen, Mikael Kaur, Amanpreet Pääkkönen, Mirva von Schantz-Fant, Сarina Ohlmeyer, Michael Wennerberg, Krister Kauko, Otto Koch, Raphael Aittokallio, Tero Antero Taipale, Mikko Westermarck, Jukka . PP2A-based triple-strike therapy overcomes mitochondrial apoptosis resistance in brain cancer cells. Molecular Oncology. 2023, 17(9), 1803-1820.  , 2023
 
1-15